- Home
- NVCT vs DSM Comparison
NVCT vs DSM Comparison
Compare NVCT & DSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVCT
- DSM
- Stock Information
- Founded
- NVCT 2020
- DSM 1989
- Country
- NVCT United States
- DSM United States
- Employees
- NVCT N/A
- DSM N/A
- Industry
- NVCT Medicinal Chemicals and Botanical Products
- DSM Investment Managers
- Sector
- NVCT Health Care
- DSM Finance
- Exchange
- NVCT Nasdaq
- DSM Nasdaq
- Market Cap
- NVCT 249.1M
- DSM 270.9M
- IPO Year
- NVCT 2022
- DSM N/A
- Fundamental
- Price
- NVCT $8.99
- DSM $5.75
- Analyst Decision
- NVCT Strong Buy
- DSM
- Analyst Count
- NVCT 3
- DSM 0
- Target Price
- NVCT $17.00
- DSM N/A
- AVG Volume (30 Days)
- NVCT 157.3K
- DSM 161.7K
- Earning Date
- NVCT 05-06-2025
- DSM 01-01-0001
- Dividend Yield
- NVCT N/A
- DSM 3.97%
- EPS Growth
- NVCT N/A
- DSM N/A
- EPS
- NVCT N/A
- DSM N/A
- Revenue
- NVCT N/A
- DSM N/A
- Revenue This Year
- NVCT N/A
- DSM N/A
- Revenue Next Year
- NVCT N/A
- DSM N/A
- P/E Ratio
- NVCT N/A
- DSM N/A
- Revenue Growth
- NVCT N/A
- DSM N/A
- 52 Week Low
- NVCT $4.44
- DSM $4.69
- 52 Week High
- NVCT $11.80
- DSM $6.05
- Technical
- Relative Strength Index (RSI)
- NVCT 47.46
- DSM 60.00
- Support Level
- NVCT $8.01
- DSM $5.63
- Resistance Level
- NVCT $9.62
- DSM $5.74
- Average True Range (ATR)
- NVCT 1.04
- DSM 0.07
- MACD
- NVCT -0.16
- DSM 0.04
- Stochastic Oscillator
- NVCT 27.96
- DSM 94.74
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.
About DSM BNY Mellon Strategic Municipal Bond Fund Inc.
BNY Mellon Strategic Municipal Bond Fund, Inc. is a diversified closed-end management investment company. Its investment objective is to seek to maximize current income exempt from federal income tax to the extent consistent with the preservation of capital.